📰 Augmented Efficacy News

Augmented Efficacy News Today

Fast, Ad-Free News Updates

Stay updated with breaking news from Augmented Efficacy. Real-time updates on events, politics, business and more.

NA Proactive news snapshot: Vuzix Corporation, Q BioMed Inc, Gungnir Resources Inc, MySize Inc, Appia Rare Earths and Uranium Corp, Psyched Wellness Inc UPDATE ...

July 26, 2022

Vuzix Corporation has entered into a distribution agreement with Westbase.io, a leading distributor of extended reality (XR), 4G/5G and internet of things...

United States United Kingdom Canada General Dominican Republic Canaccord Genuity Lionel Bonhomme

Source: proactiveinvestors.com

NA Proactive news snapshot: Q BioMed Inc, Gungnir Resources Inc, MySize Inc, Appia Rare Earths and Uranium Corp, Psyched Wellness Inc UPDATE ...

July 26, 2022

Vuzix Corporation has entered into a distribution agreement with Westbase.io, a leading distributor of extended reality (XR), 4G/5G and internet of things...

United States United Kingdom Canada General Dominican Republic Canaccord Genuity Lionel Bonhomme

Source: proactiveinvestors.com

Q BioMed announces publication of pre-clinical research showing superior safety and efficacy against current first line therapy of its drug candidate Uttroside-B for liver cancer

July 26, 2022

/PRNewswire/ -- Q BioMed, Inc. (OTCQB: QBIO) a commercial-stage biotechnology development company announces a new publication supporting the potential superior...

United States South Korea Ruby John Anto Denis Corin Keith Pinder Rajiv Gandhi Centre For Biotechnology

Source: prnewswire.com

Explore More Categories

World News India News Business Technology Sports Entertainment Health Science

Navigation

Augmented Efficacy News Today

NA Proactive news snapshot: Vuzix Corporation, Q BioMed Inc, Gungnir Resources Inc, MySize Inc, Appia Rare Earths and Uranium Corp, Psyched Wellness Inc UPDATE ...

NA Proactive news snapshot: Q BioMed Inc, Gungnir Resources Inc, MySize Inc, Appia Rare Earths and Uranium Corp, Psyched Wellness Inc UPDATE ...

Q BioMed announces publication of pre-clinical research showing superior safety and efficacy against current first line therapy of its drug candidate Uttroside-B for liver cancer

Explore More Categories